熊去氧胆酸钠盐 T29078
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 2898-95-5 | ¥150.00 | 询底价 |
100 mg | 2898-95-5 | ¥348.00 | 询底价 |
50 mg | 2898-95-5 | ¥243.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ursodeoxycholic acid sodium
描述: Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) 是一种天然存在的次级胆汁酸,具有抗炎和细胞保护活性。Ursodeoxycholic acid sodium 作为信号分子,通过与胆汁酸激活受体相互作用发挥其作用,包括 G 蛋白偶联胆汁酸受体 5 (TGR5) 和法尼醇 X 受体 (FXR)。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 120 mg/mL (289.47 mM)
关键字: Ursodeoxycholic acid sodium | gastrointestinal diseases | lipid metabolism | Ursodeoxycholate | GPBAR1 | intestinal barrier integrity | NR1H4 | Ursodeoxycholic acid | G-protein coupled receptor 19 | hepatic | UCDA | inhibit | oral | GPCR19 | Inhibitor | Ursodeoxycholic Acid | G protein-coupled Bile Acid Receptor 1 | Endogenous Metabolite | Ursodiol | FXR | secondary bile acid | TGR5
相关产品: Vonafexor | Hyodeoxycholic acid | BAR502 | T0901317 | LY367385 | Nidufexor | ZLY28 | Gly-β-MCA | Tauro-β-muricholic acid | Altenusin
相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | GPCR Compound Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | PPI Inhibitor Library | Metabolism Compound Library
熊去氧胆酸钠盐 T29078信息由TargetMol中国为您提供,如您想了解更多关于熊去氧胆酸钠盐 T29078报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途